As the
prostate-specific antigen tests remains under fire for its track record of
inaccuracies, researchers in Sweden believe they’ve found a better blood test.
Designed to screen for prostate cancer using a large number of markers, the
test has held up well in studies so far for its ability to accurately detect
aggressive prostate cancer.